1998
DOI: 10.1016/s0014-2999(98)00451-8
|View full text |Cite
|
Sign up to set email alerts
|

Possible mechanism for the anemia induced by candesartan cilexetil (TCV-116), an angiotensin II receptor antagonist, in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
21
0

Year Published

2001
2001
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 31 publications
(25 citation statements)
references
References 22 publications
3
21
0
Order By: Relevance
“…In this model, a 2-week infusion of angiotensin II corrected the hematocrit to near wild-type levels, strongly implicating a direct role of angiotensin II in erythropoiesis. Consistent with this finding, angiotensin II receptor antagonists reduce hemoglobin, hematocrit, and erythrocyte counts in rats (Naeshiro et al, 1998).…”
Section: G Erythropoiesissupporting
confidence: 75%
“…In this model, a 2-week infusion of angiotensin II corrected the hematocrit to near wild-type levels, strongly implicating a direct role of angiotensin II in erythropoiesis. Consistent with this finding, angiotensin II receptor antagonists reduce hemoglobin, hematocrit, and erythrocyte counts in rats (Naeshiro et al, 1998).…”
Section: G Erythropoiesissupporting
confidence: 75%
“…In this regard, in early diabetes renal blood flow is increased, and it is plausible that resulting increased oxygen supply suppresses Epo production. In line with this, blockade of the renin-angiotensin system in rats increased interstitial blood flow (due to decreased intrarenal resistance) and anemia (60), possibly explaining the drop in hematocrit typically observed in the first month of therapy with angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers in patients (61). While supplementation with recombinant Epo is highly effective, it is associated with high costs, and its effectiveness can be impaired by antibody formation.…”
Section: Impaired Epo Production As Cause Of Anemiamentioning
confidence: 86%
“…For instance, the renin-angiotensin system stimulates the hematopoietic progenitor cell and induces the growth of early erythroid progenitors (24,25). ACE inhibitors and angiotensin II receptor antagonist might suppress erythropoiesis (26,27). In peritoneal dialysis patients, genotype II is associated with both lower ACE levels and higher EPO dose requirements (28,29).…”
Section: Discussionmentioning
confidence: 99%